1. Home
  2. GLOO vs PRLD Comparison

GLOO vs PRLD Comparison

Compare GLOO & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gloo Holdings Inc.

GLOO

Gloo Holdings Inc.

N/A

Current Price

$2.58

Market Cap

276.7M

Sector

Technology

ML Signal

N/A

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

N/A

Current Price

$3.25

Market Cap

260.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLOO
PRLD
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
276.7M
260.2M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
GLOO
PRLD
Price
$2.58
$3.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
★ $11.17
$8.80
AVG Volume (30 Days)
232.2K
★ 257.6K
Earning Date
09-09-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.17
23.21
EPS
N/A
★ N/A
Revenue
★ $94,660,000.00
$12,140,000.00
Revenue This Year
$111.41
$74.34
Revenue Next Year
$42.96
$85.56
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 307.74
73.43
52 Week Low
$2.60
$1.30
52 Week High
$9.98
$6.83

Technical Indicators

Market Signals
Indicator
GLOO
PRLD
Relative Strength Index (RSI) 30.49 36.56
Support Level N/A $2.69
Resistance Level $3.20 $3.32
Average True Range (ATR) 0.23 0.31
MACD 0.00 -0.03
Stochastic Oscillator 11.42 6.32

Price Performance

Historical Comparison
GLOO
PRLD

About GLOO Gloo Holdings Inc.

Gloo Holdings Inc is engaged in building a technology platform company. It has provided a breadth of products, services, and solutions to the two primary stakeholders at the core of the faith and flourishing ecosystem: (1) network capability providers (NCPs) and (2) the churches and frontline organizations (CFLs) it serves. The company serves as a digital infrastructure between NCPs and CFLs. By facilitating efficient exchange between the two, Gloo enables both sides to succeed; CFLs gain access to resources and NCPs benefit from efficient distribution and targeted reach. This creates a virtuous cycle, strengthening the platform with each interaction. The Gloo platform includes a suite of technology, marketplace, and service solutions offered directly from Gloo or from Gloo's subsidiaries.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: